Alport syndrome: HLA association and kidney graft outcome.

Alport syndrome (AS) is a genetic disease of type IV collagen involving non-homogeneous patterns of inheritance characterized clinically by the presence of progressive haematuric nephritis leading to end-stage renal disease (ESRD), hearing loss and/or ophthalmologic abnormalities. The aim of this study was to investigate, in a cohort of AS patients who had undergone a kidney graft (KG) or who were still on a waiting list for a KG, (a) whether there is a correlation between AS and HLA antigen expression, and (b) long-term graft outcome in transplant patients. The AS cohort was represented by 34 ESRD patients, of whom 25 received a KG and the remaining nine were still on a waiting list. AS transplant patients represented 2.78% of 899 first KGs performed at our centre (Transplantation Department at S. Martino Hospital, Genoa) between 1983 and 2002. Grafts were procured from cadaveric donors in 18 cases and from living, related donors in seven cases. All AS transplant patients had a post-transplant follow-up period of at least 12 months. Results showed that: (i) the frequency of the HLA-DRB1*16 antigen was significantly increased in the whole AS cohort as compared to 128 healthy subjects (HS) (corrected P-value 0.0026; relative risk 7.20) as well as to 232 non-AS ESRD patients on a waiting list for KG (corrected P-values 0.0156; relative risk 4.67); (ii) 5- and 10-year graft survivals in the AS transplant patients were 80 and 73%, respectively, and did not differ from those of a control group represented by 25 non-AS KG recipients matched for sex, age, number of HLA mismatches and immunosuppressive treatment. Increased frequency of HLA-DRB1*16 in AS patients may reflect a linkage disequilibrium with genes coding for collagen synthesis.

[1]  K. Tryggvason,et al.  Alport's syndrome, Goodpasture's syndrome, and type IV collagen. , 2003, The New England journal of medicine.

[2]  M. Budisavljevic,et al.  Renal transplant in patients with Alport's syndrome. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  H. Smeets,et al.  X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. , 2000, Journal of the American Society of Nephrology : JASN.

[4]  C. Cremers,et al.  Hearing Loss in the Nonocular Stickler Syndrome Caused by a COL11A2 Mutation , 2000, The Laryngoscope.

[5]  A. Rees,et al.  Anti-Glomerular Basement Membrane Disease , 2020, Definitions.

[6]  A. Rees,et al.  The HLA complex in Goodpasture's disease: a model for analyzing susceptibility to autoimmunity. , 1999, Kidney international.

[7]  C. Kashtan.  Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes. , 1999, Medicine.

[8]  R. Torra,et al.  Autosomal recessive Alport syndrome: linkage analysis and clinical features in two families. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  A. Nocera,et al.  Correlation between angiotensin-converting enzyme gene insertion/deletion polymorphism and kidney graft long-term outcome in pediatric recipients: a single-center analysis. , 1999, Transplantation.

[10]  E. Donadi,et al.  Association of Alport's syndrome with HLA-DR2 antigen in a group of unrelated patients. , 1998, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[11]  E. Mariman,et al.  A Stickler syndrome gene is linked to chromosome 6 near the COL11A2 gene. , 1994, Human molecular genetics.

[12]  H. Smeets,et al.  Identification of mutations in the α3(IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome , 1994, Nature Genetics.

[13]  U. Helmchen,et al.  Kidney transplantation in Alport's syndrome: long-term outcome and allograft anti-GBM nephritis. , 1992, Clinical nephrology.

[14]  T. Yang-Feng,et al.  Colocalization of the genes for the α3(IV) and α4(IV) chains of type IV collagen to chromosome 2 bands q35–q37 , 1992 .

[15]  J. Squifflet,et al.  OUTCOME OF THIRTY PATIENTS WITH ALPORT'S SYNDROME AFTER RENAL TRANSPLANTATION , 1991, Transplantation.

[16]  R. Butkowski,et al.  Posttransplant anti-glomerular basement membrane nephritis in related males with Alport syndrome. , 1990, The Journal of laboratory and clinical medicine.

[17]  D. Sheer,et al.  Molecular cloning of alpha 5(IV) collagen and assignment of the gene to the region of the X chromosome containing the Alport syndrome locus. , 1990, American journal of human genetics.

[18]  R. Eddy,et al.  Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Trowsdale,et al.  The human alpha 2(XI) collagen gene (COL11A2) maps to the centromeric border of the major histocompatibility complex on chromosome 6. , 1989, Genomics.

[20]  J. Mackenzie,et al.  The genes coding for human pro alpha 1(IV) collagen and pro alpha 2(IV) collagen are both located at the end of the long arm of chromosome 13. , 1988, American journal of human genetics.

[21]  J. Feingold,et al.  Genetics of Alport's syndrome , 1987, Pediatric Nephrology.

[22]  R. Vaughan,et al.  Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes. , 1997, Kidney international.

[23]  Y. Bar-Khayim,et al.  Occurrence of hereditary nephritis, pretibial epidermolysis bullosa and beta-thalassemia minor in two siblings with end-stage renal disease. , 1988, Nephron.